Stanford researchers have developed a novel, multi-specific chimeric antigen receptor (CAR) T-cell therapy designed to overcome the key challenges of treating solid tumors, including tumor heterogeneity, immune evasion, and CAR T-cell exhaustion.
Stanford researchers developed and patented a multiplexed immunohistochemistry method called multiplexed ion beam imaging (MIBI), which uses antibodies tagged with non-biological elemental isotopes (e.g. rare earth elements) and secondary ion mass spectroscopy.
Stanford scientists have developed fully human CD19-targeted CAR T cells designed to overcome the limitations of current CAR T cell therapies, particularly in treating low CD19 density blood cancers.
Riffbot.ai is a web-based platform that leverages AI-powered, customizable chatbots to generate dynamic, personalized self-reflection experiences for learners while providing real-time insights to enhance engagement and improve learning outcomes at scale.
Stanford researchers have developed a novel, inverse-designed wavelength division multiplexer (WDM) that integrates high-performance Bragg gratings for use in optical communication systems.
Researchers at Stanford have developed an innovative molecular engineering strategy to enhance the stability and performance of polymer semiconductors (PSCs).
Stanford scientists have discovered that a specific protein signaling pathway can promote regenerative wound healing by suppressing fibrosis-related mechanosignaling.
Stanford researchers have developed a highly effective B7-H3 chimeric antigen receptor (CAR) for CAR-T cell therapy, designed to enhance binding and cytotoxicity against B7-H3 expressing solid tumors, offering a promising treatment for various cancers.
Stanford researchers in Prof. Michelle Monje's lab have developed a method for treating cognitive impairment (aka brain fog) caused by cancer immunotherapy.
Stanford scientists have developed an innovative Double-double (DD), thin-ply laminate technology that challenges traditional composite design rules to simultaneously reduce weight and cost.
Stanford researchers have developed a software platform featuring an integrated digital twin framework to enable 24/7, carbon-free operations of electric vehicle (EV) fleets.
Stanford researchers have developed a new class of asymmetric ether solvents — both non-fluorinated and fluorinated — for next-generation lithium-metal batteries.
Researchers in Prof. Hongjie Dai's laboratory have developed a simple process to easily deposit plasmonic nanoscopic gold films on a variety of surfaces.
Hematopoietic stem and progenitor cells, collectively "HSPCs", are multipotent cells that can self-renew and differentiate into all types of blood cells, including cells of both myeloid and lymphoid lineage.
Osteopontin is a protein involved in the pathogenesis of cancer and chronic inflammatory diseases. Antibodies are a powerful tool that can be used to target this protein and regulate its pathway.